Bionik Laboratories Corp.
Bionik Laboratories Corp. (BNKL) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 31 transactions totaling $1.0M, demonstrating a bullish sentiment with $1.0M in net insider flow. The most recent transaction on Jun 13, 2023 involved a transaction of 186,111 shares valued at $111.7K.
BNKL Insider Activity Summary
Who Is Buying BNKL Stock?
No significant insider buying has been recorded for BNKL in the recent period.
Who Is Selling BNKL Stock?
No significant insider selling has been recorded for BNKL in the recent period.
Is Bionik Laboratories Corp. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for BNKL is bullish with an Insider Alignment Score of 100/100 and a net flow of $1.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
BNKL Frequently Asked Questions
Understanding BNKL Insider Activity
Insider trading at Bionik Laboratories Corp. (BNKL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading BNKL stock, having executed 31 transactions in the past 90 days. The most active insider is Remi Gaston-dreyfus (Executive), who has made 15 transactions totaling $12.0M.
Related Tools
Track Bionik Laboratories Corp. Insider Activity
Get notified when executives and directors at BNKL file new Form 4 transactions